As a valued Relias Media subscriber, you can find the latest issue of your publication online. The articles below provide timely strategies and research for healthcare providers:
These reviews of studies presented at the 2020 International Stroke Conference were written by Neurology Alert's editor after personal attendance at the presentations, followed by review of the simultaneous publications in Stroke. All comments and opinions are solely those of the editor.
Zilucoplan, a macrocyclic peptide that binds complement component C5, showed promise as an effective agent for treatment of generalized myasthenia gravis in a Phase II trial.
This paper illustrates that, of the confirmed genetic forms of Parkinson’s disease, there are common cognitive and psychiatric features, thus adding to our knowledge of the clinical phenotype of these genetic forms.
Relias Media is offering free, unlimited access to our COVID-19-related content to help healthcare professionals stay up to date and respond to the pandemic. Click here to access our COVID-19 resource page!
Financial Disclosure: Editor in Chief Matthew Fink, MD, Peer Reviewer M. Flint Beal, MD, Editorial Group Manager Leslie Coplin, Editor Jason Schneider, Executive Editor Shelly Morrow Mark, and Accreditations Director Amy M. Johnson, MSN, RN, CPN, report no financial relationships relevant to this field of study.
